Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Gray hair can potentially be reversed, leading to new treatments.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Targeting protein lactylation may improve skin disease treatments.

Aesthetic treatments can safely improve cancer patients' quality of life with oncologist approval.

LTBP1 is a key regulator in diseases and a potential target for new treatments.

Keratinocyte stem cells are crucial for skin renewal and have potential in wound healing and tissue regeneration.

Vitiligo is influenced by genetics and environment, and combining these factors can improve early detection and prevention.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Plant-derived extracellular vesicles show promise for treating diseases like cancer and inflammation.

Immune cells are essential for early hair and skin development and healing.

Pexidartinib often causes liver issues and fatigue, especially in women.

Icariin can regulate macrophages and may help treat inflammation, cancer, bone disorders, and fibrotic diseases.

The article concludes that while we understand a lot about how melanocytes age and how this can prevent cancer, there are still unanswered questions about certain pathways and genes involved.

Older skin has higher cancer risk due to inflammation and stem cell issues.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Targeting specific cell interactions may help treat skin fibrosis.

Dissolving microneedles offer efficient, minimally invasive drug delivery through the skin.

Medications can cause eye problems, so regular eye check-ups are important.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Scientists discovered a new way UVB light increases skin pigmentation through the ATP-P2X7 pathway.